PitchSend

Investor Presentaiton

ENILIVE: FINANCIALS ATTRACTIVE GROWTH WITH WELL-CONTROLLED COST PROFILE 15 STRONG EBITDA INCREASE IN THE 4YP PRO-FORMA EBITDA ADJ | BLN € ORGANIC CAPEX | BLN € ~1.0 CAGR ~20% 1.2 >1.6 0.5 35% 40% ΙΟ 65% 65% 27% 60% AVG 2024-27 2024 2025 2027 Biorefining ■Marketing AVG 24-27 MARKETING EBITDA PROVIDING STEADY CONTRIBUTION BIOREFINING EBITDA UNDERPINNED BY CAPACITY GROWTH & THROUGHPUT INCREASE CAPEX TO BENEFIT FROM RETROFITTING, ECONOMY OF SCALE AND MATURING TECHNOLOGY Biorefining ORGANICALLY SELF-FUNDING SELECTIVE M&A FITS WITHIN OVERALL GROWTH STRATEGY Stay-in-business ■Development ■Marketing AVERAGE ROACE (2024-27) 15+%

View entire presentation